Cellaca® PLX image cytometer as an alternative for immunophenotyping, GFP/RFP transfection efficiencies, and apoptosis analysis.

Autor: Franco Nitta C; Department of Consumables and Reagent Development, USA. Electronic address: carolina.franconitta@revvity.com., Pierce M; Department of Consumables and Reagent Development, USA., Hem S; Department of Consumables and Reagent Development, USA., Parker A; Department of Consumables and Reagent Development, USA., Bell J; Department of Advanced Technology R&D, USA., Huang Y; Department of Advanced Technology R&D, USA., Patel S; Department of Advanced Technology R&D, USA., Gundimeda SK; Department of Engineering, USA., Dings J; Department of Engineering, USA., Shaw N; Department of Engineering, USA., Dobrowolski M; Department of Software Development, Revvity Health Sciences, Inc, 360 Merrimack St, Suite 200, Lawrence, MA, 01843, USA., Flanagan K; Department of Software Development, Revvity Health Sciences, Inc, 360 Merrimack St, Suite 200, Lawrence, MA, 01843, USA., Stefanski J; Department of Software Development, Revvity Health Sciences, Inc, 360 Merrimack St, Suite 200, Lawrence, MA, 01843, USA., Vasani D; Department of Software Development, Revvity Health Sciences, Inc, 360 Merrimack St, Suite 200, Lawrence, MA, 01843, USA., Delany J; Department of Software Development, Revvity Health Sciences, Inc, 360 Merrimack St, Suite 200, Lawrence, MA, 01843, USA., Hedrick C; Department of Software Development, Revvity Health Sciences, Inc, 360 Merrimack St, Suite 200, Lawrence, MA, 01843, USA., Ratnani S; Department of Software Development, Revvity Health Sciences, Inc, 360 Merrimack St, Suite 200, Lawrence, MA, 01843, USA., Karukappadath M; Department of Software Development, Revvity Health Sciences, Inc, 360 Merrimack St, Suite 200, Lawrence, MA, 01843, USA., Cortez A; Department of Software Development, Revvity Health Sciences, Inc, 360 Merrimack St, Suite 200, Lawrence, MA, 01843, USA., Parrish K; Department of Software Development, Revvity Health Sciences, Inc, 360 Merrimack St, Suite 200, Lawrence, MA, 01843, USA., Claflin S; Department of Software Development, Revvity Health Sciences, Inc, 360 Merrimack St, Suite 200, Lawrence, MA, 01843, USA., Battacharya S; Department of Advanced Technology R&D, USA., Williamson C; Department of Advanced Technology R&D, USA., Li P; Department of Consumables and Reagent Development, USA; Department of Advanced Technology R&D, USA; Department of Engineering, USA; Department of Software Development, Revvity Health Sciences, Inc, 360 Merrimack St, Suite 200, Lawrence, MA, 01843, USA., Qiu J; Department of Consumables and Reagent Development, USA; Department of Advanced Technology R&D, USA; Department of Engineering, USA; Department of Software Development, Revvity Health Sciences, Inc, 360 Merrimack St, Suite 200, Lawrence, MA, 01843, USA., Kuksin D; Department of Consumables and Reagent Development, USA; Department of Advanced Technology R&D, USA., Lin B; Department of Consumables and Reagent Development, USA; Department of Advanced Technology R&D, USA., Smith T; Department of Engineering, USA; Department of Software Development, Revvity Health Sciences, Inc, 360 Merrimack St, Suite 200, Lawrence, MA, 01843, USA., Chan LL; Department of Consumables and Reagent Development, USA; Department of Advanced Technology R&D, USA; Department of Engineering, USA.

Publikováno v: Analytical biochemistry [Anal Biochem] 2024 Jan 15; Vol. 685, pp. 115389. Date of Electronic Publication: 2023 Nov 10.

1010 - Immunotherapy: CELL IDENTITY, COUNT, AND VIABILITY FOR CRITICAL QUALITY ATTRIBUTES USING THE CELLACA PLX IMAGE CYTOMETER

Autor: Lin, B., Nitta, C., Parker, A., Hem, S., Pierce, M., Smith, T., Ratnani, S., Dobrowolski, M., Gundimeda, S., Kuksin, D., Chan, L.

Publikováno v: In Cytotherapy May 2023 25(6) Supplement:S216-S216

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Practical Characterization Strategies for Comparison, Qualification, and Selection of Cell Viability Detection Methods for Cellular Therapeutic Product Development and Manufacturing.

Autor: Huang Y; Revvity Health Sciences, Inc., 360 Merrimack St., Suite 200, Lawrence, MA, 01843, USA. yongyang.huang@revvity.com., Watkins R; Horizon Discovery Ltd., Cambridge, CB25 9TL, UK., Patel S; Revvity Health Sciences, Inc., 360 Merrimack St., Suite 200, Lawrence, MA, 01843, USA., Pierce M; Revvity Health Sciences, Inc., 360 Merrimack St., Suite 200, Lawrence, MA, 01843, USA., Franco Nitta C; Revvity Health Sciences, Inc., 360 Merrimack St., Suite 200, Lawrence, MA, 01843, USA., Qazi H; Revvity Health Sciences, Inc., 360 Merrimack St., Suite 200, Lawrence, MA, 01843, USA., Rice WL; Revvity Health Sciences, Inc., 360 Merrimack St., Suite 200, Lawrence, MA, 01843, USA., Lin B; Revvity Health Sciences, Inc., 360 Merrimack St., Suite 200, Lawrence, MA, 01843, USA., Lowe C; Horizon Discovery Ltd., Cambridge, CB25 9TL, UK., le Sage C; Horizon Discovery Ltd., Cambridge, CB25 9TL, UK., Chan LL; Revvity Health Sciences, Inc., 360 Merrimack St., Suite 200, Lawrence, MA, 01843, USA.

Publikováno v: Journal of fluorescence [J Fluoresc] 2024 Sep; Vol. 34 (5), pp. 2263-2278. Date of Electronic Publication: 2023 Sep 22.

A novel concentration and viability detection method for Brettanomyces using the Cellometer image cytometry.

Autor: Martyniak B; Cooperative Extension and the School of Food and Agriculture, University of Maine, Orono, ME, 04469, USA., Bolton J; Cooperative Extension and the School of Food and Agriculture, University of Maine, Orono, ME, 04469, USA., Kuksin D; Department of Technology R&D, Nexcelom Bioscience LLC, 360 Merrimack St. Building 9, Lawrence, MA, 01843, USA., Shahin SM; Department of Technology R&D, Nexcelom Bioscience LLC, 360 Merrimack St. Building 9, Lawrence, MA, 01843, USA., Chan LL; Department of Technology R&D, Nexcelom Bioscience LLC, 360 Merrimack St. Building 9, Lawrence, MA, 01843, USA. lchan@nexcelom.com.

Publikováno v: Journal of industrial microbiology & biotechnology [J Ind Microbiol Biotechnol] 2017 Jan; Vol. 44 (1), pp. 119-128. Date of Electronic Publication: 2016 Nov 12.